Publisher's Synopsis
Topics discussed in these proceedings include membrane biocompatibility, catabolic factors associated with dialysis therapy, pharmacological therapy in dialyzed patients, erythropoietin and renal anemia, new developments in CAVH, CAPD and plasmapheresis, renal replacement therapy in acute renal failure, and plasmapheresis therapy in systemic diseas